Ticker
ATYRCompany Name
ATYR PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -66.64M | 0% | $ 0 |
3/31/2025 | $ -63.41M | 0% | $ 0 |
12/31/2024 | $ -64.02M | -27243.83% | $ 235K |
9/30/2024 | $ -63.82M | -27155.74% | $ 235K |
6/30/2024 | $ -57.9M | -9846.43% | $ 588K |
3/31/2024 | $ -53.93M | -9171.6% | $ 588K |
12/31/2023 | $ -50.39M | -14274.5% | $ 353K |
9/30/2023 | $ -43.15M | -401.81% | $ 10.74M |
6/30/2023 | $ -45.05M | -433.8% | $ 10.39M |
3/31/2023 | $ -45.14M | -434.59% | $ 10.39M |
EBIT / Revenues
(=) EBIT %
EBIT % for ATYR PHARMA INC is calculated as follows: EBIT [ $ -17.27M ] / Revenues [ $ 8.55M ]
(=) EBIT % [ -202.02% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |